Neurological syndromes associated with GAD antibodies include SPS, cerebellar ataxia, limbic and extralimbic encephalitis, nystagmus/oculomotor dysfunction, drug-resistant epilepsy, paraneoplastic SPS, and progressive encephalopathy with rigidity and myoclonus. This evidence concerns the gene GAD1 and cerebellar ataxia.